Moderna concludes advanced talks with EU for COVID-19 vaccine supply


Aug 24 (Reuters) - Moderna Inc MRNA.O said on Monday it has concluded advanced exploratory talks with the European Commission to supply 80 million doses of its COVID-19 vaccine candidate.

The potential agreement provides for an option for member states to buy an additional 80 million doses for a total of up to 160 million doses, the company said.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Arun Koyyur)

((;; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132; Twitter: @AnkurBanerjee17;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.